Multiple functions of polypeptides mediated by distinct domains interacting with different receptors

Peptides

Volumn 20, Issue 11, 1999, Pages 1385-1388

  Jiang, Chun Lei ^a   Lu, Chang Lin ^a   Chen, Yi Zhang ^a   Liu, Xin Yuan ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Angiotensin II; Corticotrophin releasing factor; Cytokines; Domain; Interferon ; Interleukin 2 (IL 2); Opioid peptides; Polypeptides; Receptors; Relationship of structure and function; Signal transduction; Vasopressin

Indexed keywords

ALPHA INTERFERON; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYTOKINE; INTERLEUKIN 2; OPIATE RECEPTOR; POLYPEPTIDE; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION;

EID: 0032786230     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00147-3     Document Type: Review

References (30)

1. Bazan J.F. Unraveling the structure of IL-2. Science. 257:1992;410-412.
2. Blalock J.E., Smith E.M. Human leukocyte interferon structural and biological relatedness to adrenocorticotropic hormone and endorphins . Proc Natl Acad Sci USA. 77:1980;5972-5974.
3. Brinkmeier H., Kaspar A., Wietholter H., Rudel R. IL-2 inhibits sodium currents in human muscle cells. Eur J Physiol. 420:1992;621-623.
4. Buchli P., Ciardelli T. Structural and biologic properties of a human aspartic acid-126 IL-2 analog. Arch Biochem Biophys. 307:1993;411-415.
5. de Wied D., Diamant M., Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol. 14:1993;251-302.
6. Hall A.K., Rao M.S. Cytokines and neurokines related ligands and related receptors . Trends Neurosci. 15:1992;35-37.
7. Hanisch U.-K., Quirion R. IL-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev. 21:1996;246-284.
8. Jiang C.L., Lu C.L., Liu X.Y. Multiple actions of cytokines on the CNS. Trends Neurosci. 18:1995;296.
9. Jiang C.L., Lu C.L., Liu X.Y. The Molecular basis for bidirectional communication between the immune and neuroendocrine systems. Domest Anim Endocrinol. 15:1998;363-369.
10. Jiang C.L., Lu C.L., Liu X.Y. IL-2 and its effect in the central nervous system. Biol Signals. 7:1998;148-156.
11. Kandel E.R. Cellular mechanisms of learning and the biological basis of individuality. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of neural science, 3rd Edition. 1991;1009-1031 Elsevier Science Publishing Co. Inc. Press, Amsterdam.
12. + channels no evidence for involvement of the IL-2 receptor . J Physiol. 426:1994;61-67.
13. Kent S., Bluthe R.-M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci USA. 89:1992;9117-9120.
14. Li Z.Y., Yang H.H., Huang J.Q., Fan P.F., Liu X.Y. Competition of opioid receptor by human recombinant IL-2. J. Interferon Res. 10:(suppl 1):1990;s141.
15. Lohof A.M., Ip N.Y., Poo M.M. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature. 363:1993;350-353.
16. Lu B., Figurov A. Role of neurotrophins in synapse development and plasticity. Rev Neurosci. 8:1997;1-12.
17. Mott H.R., Driscoll P.C., Boyd J., Cooke R.M., Weir M.P., Campbell I.D. Secondary structure of human IL-2 from 3D heteronuclear NMR experiments. Biochemistry. 31:1992;7741-7744.
18. Proebstle T., Mitrovics M., Schneider M., Hombach V., Rudel R. Recombinant IL-2 acts as a class I antiarrhythmic drug on human cardiac sodium channels. Eur J Physiol. 429:1995;462-469.
19. Sadoshima J., Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 59:1997;551-571.
20. - current in identified Aplysia neurons. J Neurosci Res. 33:1992;461-465.
21. Segal R.A. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci. 19:1996;463-489.
22. Smith E.M., Blalock J.E. Human lymphocyte production of corticotrophin and endorphin-like substances association with leukocyte interferon . Proc Natl Acad Sci USA. 78:1981;7530-7534.
23. Turnbull A.V., Vale W., Ribier C. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur J Pharmacol. 303:1996;213-216.
24. Van den Bergh P., Rozing J., Nagelkerken L. Identification of distinct sites of β-endorphin that stimulate lymphokine production by murine CD4+ T cells. Lymphokine Cytokine Res. 13:1994;63-69.
25. Wang Z., Zheng Z., Sun L., Liu X. Substitutions at the Glu62 residue of human IL-2 differentially affect its binding to the alpha chain and the beta gamma complex of the IL-2 receptor. Eur J Immunol. 25:1995;1212-1216.
26. Wehling M. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol. 59:1997;365-393.
27. Wei E.T., Thomas H.A. Anti-inflammatory peptide agonists. Annu Rev Pharmacol Toxicol. 33:1993;91-108.
28. Wei E.T., Thomas H.A., Price J.S., Kishimoto T. [D-Pro5]Corticotropin-releasing factor analogs as selective agonists at corticotropin-releasing factor receptors. Eur J Pharmacol. 306:1996;161-164.
29. Xu D., Jiang C.L., Shi Y., Sun L.Y., Xu J.F., Cao L., Liu X.Y. Structure and function studies of human IL-2 with Asp-20 replaced by alkaline amino acid residues. Chin J Biochem Biophys. 27:1995;59-64.
30. Yao R., Cooper G. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2006.